Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444418 · ClinicalTrials.gov registry record · Phase 3
Medication and Counseling for Controlled Drinking (Project SMART)
A Phase 3 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00444418 is a Phase 3 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 200 participants.
The verdict
NCT00444418, a Phase 3 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce their drinking to healthier levels. More information on the study is available at www.projectsmartnyc.org.
Interventions
- DRUG Naltrexone
- BEHAVIORAL Modified Behavioral Self-Control Psychotherapy
- BEHAVIORAL Brief Behavioral Compliance Enhancement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444418
The ClinicalTrials.gov registry entry for NCT00444418 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Naltrexone is the first listed.
NCT00444418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444418 about?
NCT00444418 is a clinical study titled "Medication and Counseling for Controlled Drinking (Project SMART)". The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce their drinking to healthier levels. More information on the study is available at www.projectsmartnyc.org.
What is the current status of trial NCT00444418?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2006-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00444418?
The interventions under investigation include: Naltrexone (DRUG), Modified Behavioral Self-Control Psychotherapy (BEHAVIORAL), Brief Behavioral Compliance Enhancement Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00444418?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.